A novel β-adrenergic response element regulates both basal and agonist-induced expression of cyclin-dependent kinase 1 gene in cardiac fibroblasts

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 6, 2014, Pages

  Gaspard, Gerard J ^a   MacLean, Jessica ^a   Rioux, Danielle ^a   Pasumarthi, Kishore B S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cardiac fibroblast proliferation; CDK1; Isoproterenol; NF Y; adrenergic receptor agonist

Indexed keywords

CYCLIN DEPENDENT KINASE 1; ISOPRENALINE; NUCLEAR FACTOR Y; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CCAAT BINDING FACTOR; DNA BINDING PROTEIN; MESSENGER RNA; NFYA PROTEIN, MOUSE;

ADRENERGIC SYSTEM; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RESPONSE ELEMENT; BETA ADRENERGIC STIMULATION; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; EMBRYO; FEMALE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; MOUSE; MYOFIBROBLAST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; TRANSIENT EXPRESSION; ANIMAL; BIOSYNTHESIS; CARDIAC FIBROBLAST PROLIFERATION; CDK1; CELL CULTURE; CELL PROLIFERATION; ENZYMOLOGY; FIBROBLAST; FIBROSIS; GENETICS; HEART MUSCLE; MALE; METABOLISM; NF-Y; PATHOLOGY; Β-ADRENERGIC RECEPTOR AGONIST;

CARDIAC FIBROBLAST PROLIFERATION; CDK1; ISOPROTERENOL; NF-Y; Β-ADRENERGIC RECEPTOR AGONIST;

ADRENERGIC BETA-AGONISTS; ANIMALS; CCAAT-BINDING FACTOR; CDC2 PROTEIN KINASE; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FIBROBLASTS; FIBROSIS; ISOPROTERENOL; MALE; MICE; MYOCARDIUM; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA, MESSENGER;

EID: 84900020293     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00206.2013     Document Type: Article

References (62)

1. Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87: 521-544, 2007.
2. Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter AC. Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. Mol Cell Biol 20: 2358-2366, 2000.
3. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 291: H1015-H1026, 2006.
4. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65: 657-670, 1989.
5. Bevan JA. Norepinephrine and the presynaptic control of adrenergic transmitter release. Fed Proc 37: 187-190, 1978.
6. Born TL, Frost JA, Schonthal A, Prendergast GC, Feramisco JR. c-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol Cell Biol 14: 5710-5718, 1994.
7. Boularand S, Darmon MC, Ravassard P, Mallet J. Characterization of the human tryptophan hydroxylase gene promoter. Transcriptional regulation by cAMP requires a new motif distinct from the cAMP-responsive element. J Biol Chem 270: 3757-3764, 1995.
8. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45: 657-687, 2005.
9. Clement S, Stouffs M, Bettiol E, Kampf S, Krause KH, Chaponnier C, Jaconi M. Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation. J Cell Sci 120: 229-238, 2007.
10. Colbran RJ, Schworer CM, Hashimoto Y, Fong YL, Rich DP, Smith MK, Soderling TR. Calcium/calmodulin-dependent protein kinase II. Biochem J 258: 313-325, 1989.
11. Cote F, Schussler N, Boularand S, Peirotes A, Thevenot E, Mallet J, Vodjdani G. Involvement of NF-Y and Sp1 in basal and cAMP-stimulated transcriptional activation of the tryptophan hydroxylase (TPH) gene in the pineal gland. J Neurochem 81: 673-685, 2002.
12. Dobaczewski M, de Haan JJ, Frangogiannis NG. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res 5: 837-847, 2012.
13. Farina A, Manni I, Fontemaggi G, Tiainen M, Cenciarelli C, Bellorini M, Mantovani R, Sacchi A, Piaggio G. Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex. Oncogene 18: 2818-2827, 1999.
14. Feridooni T, Hotchkiss A, Remley-Carr S, Saga Y, Pasumarthi KB. Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes. PLoS One 6: e22801, 2011.
15. Gaspard GJ, Pasumarthi KB. Quantification of cardiac fibrosis by colour-subtractive computer-assisted image analysis. Clin Exp Pharmacol Physiol 35: 679-686, 2008.
16. Gurtner A, Manni I, Fuschi P, Mantovani R, Guadagni F, Sacchi A, Piaggio G. Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation. Mol Biol Cell 14: 2706-2715, 2003.
17. Harri MN. Metabolic and cardiovascular responses to prolonged noradrenaline load and their antagonism by beta blockade in the rat. Acta Physiol Scand 104: 402-414, 1978.
18. Houslay MD, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol 58: 659-668, 2000.
19. Iaccarino G, Dolber PC, Lefkowitz RJ, Koch WJ. Beta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta-but not alpha1-adrenergic stimulation. Hypertension 33: 396-401, 1999.
20. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation 98: 1783-1789, 1998.
21. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, Srivastava D. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 16: 233-244, 2009.
22. Jun D, Park HK, Nordin AA, Nagel JE, Kim YH. Characterization of the murine cdc2 gene. Mol Cells 8: 731-740, 1998.
23. Kelm M, Schafer S, Mingers S, Heydthausen M, Vogt M, Motz W, Strauer BE. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14: 1357-1364, 1996.
24. Kim J, Eckhart AD, Eguchi S, Koch WJ. Beta-adrenergic receptormediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J Biol Chem 277: 32116-32123, 2002.
25. Ku DH, Wen SC, Engelhard A, Nicolaides NC, Lipson KE, Marino TA, Calabretta B. c-Myb transactivates cdc2 expression via Myb binding sites in the 5'-flanking region of the human cdc2 gene. J Biol Chem 268: 2255-2259, 1993.
26. Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, Shannon RP, Bishop SP, Vatner SF. Effects of chronic beta-adrenergic receptor stimulation in mice. J Mol Cell Cardiol 29: 2735-2746, 1997.
27. Lau YH, Robinson RB, Rosen MR, Bilezikian JP. Subclassification of beta-adrenergic receptors in cultured rat cardiac myoblasts and fibroblasts. Circ Res 47: 41-48, 1980.
28. Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X, Novak L, Renfrow MB, Chen YF. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102: 185-192, 2008.
29. Liu F, Thompson MA, Wagner S, Greenberg ME, Green MR. Activating transcription factor-1 can mediate Ca(2+)-and cAMP-inducible transcriptional activation. J Biol Chem 268: 6714-6720, 1993.
30. Liu N, Lucibello FC, Korner K, Wolfraim LA, Zwicker J, Muller R. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters. Nucleic Acids Res 25: 4915-4920, 1997.
31. Liu Q, Yan H, Dawes NJ, Lu Y, Zhu H. Transcriptional activation of the p34cdc2 gene by cdc2 promoter binding factor/nuclear factor-Y in fetal rat ventricular myocytes. Circ Res 82: 251-260, 1998.
32. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239: 15-27, 1999.
33. Mantovani R, Li XY, Pessara U, Hooft van Huisjduijnen R, Benoist C, Mathis D. Dominant negative analogs of NF-YA. J Biol Chem 269: 20340-20346, 1994.
34. McGill CJ, Brooks G. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res 30: 557-569, 1995.
35. McMullen NM, Gaspard GJ, Pasumarthi KB. Reactivation of cardiomyocyte cell cycle: a potential approach for myocardial regeneration. Signal Transduction 3: 126-141, 2005.
36. McMullen NM, Zhang F, Hotchkiss A, Bretzner F, Wilson JM, Ma H, Wafa K, Brownstone RM, Pasumarthi KB. Functional characterization of cardiac progenitor cells and their derivatives in the embryonic heart post-chamber formation. Dev Dyn 238: 2787-2799, 2009.
37. Meyer TE, Habener JF. Cyclic adenosine 3=,5=-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr Rev 14: 269-290, 1993.
38. Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, Ogihara T. Role of cardiac angiotensin II in isoproterenolinduced left ventricular hypertrophy. Hypertension 19: 708-712, 1992.
39. Osawa H, Robey RB, Printz RL, Granner DK. Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene. J Biol Chem 271: 17296-17303, 1996.
40. Pick R, Jalil JE, Janicki JS, Weber KT. The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol 134: 365-371, 1989.
41. Pick R, Janicki JS, Weber KT. Myocardial fibrosis in nonhuman primate with pressure overload hypertrophy. Am J Pathol 135: 771-781, 1989.
42. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123: 255-278, 2009.
43. Rangan VS, Oskouian B, Smith S. Identification of an inverted CCAAT box motif in the fatty-acid synthase gene as an essential element for modification of transcriptional regulation by cAMP. J Biol Chem 271: 2307-2312, 1996.
44. Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IM. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 239: 1573-1584, 2010.
45. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108: 560-565, 2003.
46. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43: 169-175, 2004.
47. Serra E, Zemzoumi K, di Silvio A, Mantovani R, Lardans V, Dissous C. Conservation and divergence of NF-Y transcriptional activation function. Nucleic Acids Res 26: 3800-3805, 1998.
48. Sheng M, Thompson MA, Greenberg ME. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252: 1427-1430, 1991.
49. Small EM. The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation. J Cardiovasc Transl Res 5: 794-804, 2012.
50. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res 105: 1164-1176, 2009.
51. Sugiura N, Takishima K. Regulation of the gene promoter for extracellular signal-regulated protein kinase 2 by transcription factors NF-Y and Sp3. Biochem J 347: 155-161, 2000.
52. Sun Q, Zhang F, Wafa K, Baptist T, Pasumarthi KB. A splice variant of cyclin D2 regulates cardiomyocyte cell cycle through a novel protein aggregation pathway. J Cell Sci 122: 1563-1573, 2009.
53. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79: 215-262, 1999.
54. Turner NA, Porter KE, Smith WH, White HL, Ball SG, Balmforth AJ. Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovasc Res 57: 784-792, 2003.
55. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7: 30-37.
56. Wafa K, MacLean J, Zhang F, Pasumarthi KB. Characterization of growth suppressive functions of a splice variant of cyclin D2. PLoS One 8: e53503, 2013.
57. Webster NJ, Green S, Jin JR, Chambon P. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54: 199-207, 1988.
58. Xiang YK. Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circ Res 109: 231-244, 2011.
59. Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q. Subtype-specific alpha1-and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27: 330-337, 2006.
60. Yamada K, Tanaka T, Miyamoto K, Noguchi T. Sp family members and nuclear factor-Y cooperatively stimulate transcription from the rat pyruvate kinase M gene distal promoter region via their direct interactions. J Biol Chem 275: 18129-18137, 2000.
61. Zeng T, Yamamoto H, Bowen E, Broverman RL, Nguyen KH, Humphreys-Beher MG. Cell cycle control in isoproterenol-induced murine salivary acinar cell proliferation. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115: 271-279, 1996.
62. Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1/S and G2/M transcription. EMBO J 23: 4615-4626, 2004.